1. Intravascular coagulation in the kidneys of rats was induced by intravenous infusion of thrombin and by inhibition of fibrinolysis with tranexamic acid under a-chloralose anaesthesia. The amount of fibrin in the kidneys was measured with radioactively labelled fibrinogen. Chronic saline loading and inhibition of angiotensin I1 (ANG 11) with saralasin reduced the fibrin deposition in the kidneys. Infusion of ANG I1 had the opposite effect.
Introduction
Numerous studies on the development of experimentally induced acute renal failure have taken up the importance of the renin-angiotensin system. The main reason why this system is thought to play a part in the pathogenesis is the fact that increased ingestion of sodium chloride with depression of the renin activity of plasma and the kidneys [ 11 protects against the development of various forms of experimental acute renal failure such as that induced by injection of glycerol [21, mercuric chloride [31 and uranyl nitrate 141. Doubts about the relevance of these results have, however, been raised because the renal damage could not be prevented by angiotensin I1 (ANG 11) antagonists such as saralasin [51 or immunization against renin [61.
We have studied acute renal failure in rats after intravascular coagulation induced by infusion of thrombin during fibrinolysis inhibition and under ether anaesthesia 171. This form of acute renal failure could also be prevented by previous increased ingestion of sodium chloride [81. In a recent study 191 we have found that the ANG I1 antagonist saralasin protects against the renal damage that follows intravascular coagulation and, furthermore, reduces the amount of fibrin in the kidneys without affecting the degree of intravascular coagulation. This effect can possibly be explained by inhibition of ANG I1 during the E. Strihl, B. E. Karlberg and L. Rammer increase in the plasma renin activity (PRA) induced by ether anaesthesia.
In the present study a-chloralose anaesthesia was used to measure the effect of saralasin, ANG I1 and chronic saline loading on the fibrin deposition in the kidneys during intravascular coagulation in the rat. a-Chloralose was chosen to minimize acid-base and renal function disturbances [ 101 and to reduce activation of the renin-angiotensin system [ 1 11. Renal blood flow was measured, as it is markedly influenced by the renin-angiotensin system, affects the coagulation process and is of importance for the development of anoxic damage and acute renal failure [ 
121.

Materials and methods
Experimental animals
Two hundred and eighteen female SpragueDawley rats (Anticimex Farm, Stockholm, Sweden), weighing 215-280 g, were used. They had free access to food (Anticimex rat pellets, containing 0.08 mmol of Na/g) and tap water, with the exception of the saline-loaded rats which received drinking water containing 17 1 mmol of NaCI/l for 5-6 weeks.
Pharmacological agents a-Chloralose. Anaesthesia was induced by an intraperitoneal injection of a-chloralose [Merck; 120 mg/kg body weight (wt.)] dissolved in saline (NaCl solution, 154 mmol/l, 8 mg/ml).
Saralasin. [Sar' , Ala'IANG I1 (kindly supplied by Norwich Pharmacal Co.) was infused intravenously in a priming dose of 0.25 mg/kg body wt. for 5 min and then at a rate of 0.30 mg h-' kg-' body wt. during 90 min.
Angiotensin 11. [Val5 IANG I1 (Hypertensin, Ciba-Geigy) was given intravenously during 90 min at a rate of 0.28 mg h-' kg-' body wt. No priming dose was given as the rats did not tolerate it.
Thrombin. Bovine thrombin (Topostasin, Roche) was given intravenously for 60 min at a rate of 750 National Institute of Health (NIH) units h-I kg-I body wt.
Saralasin, ANG I1 and thrombin were dissolved in saline and given at a rate of 1.2 ml/h.
Infusions of ANG I1 and saralasin were started 30 min before the thrombin infusion.
Tranexamic acid. Tranexamic acid (Cyklokapron, Kabi; 100 mg/kg body wt.) was injected intravenously in 0.2 ml of sterile water 15 min before the thrombin infusion.
Measurement ofjbrin in the kidneys
Human fibrinogen was labelled with lZ51 by the iodine monochloride method [ 131. Fibrinogen solution (2.5 ml/kg body wt.; coaguability 90%) containing 3 mg of protein 20 pCi of 'ZsI/ml was injected into a tail vein 24 h before the experiment. The rats were anaesthetized by an intraperitoneal injection of a-chloralose. A free airway was ensured by tracheostomy. Tranexamic acid and thrombin were given through a catheter in the right external jugular vein. Immediately after the thrombin infusion a needle was introduced into the abdominal aorta and blood collected into an EDTA-tube for microhaematocrit and radioactivity measurements. Blood (4 ml) was collected in a tube containing citrate and tranexamic acid solution for determination of the plasma fibrinogen concentration 1141; this was corrected for the influence of the packed cell volume on the citrate dilution of plasma. The right lung and one kidney were dissected free from connective tissue and cleaned with filter paper. The radioactivity in blood, dissolved fibrinogen and organ samples was measured in a gamma spectrometer (LKB 1280, Ultrogamma). The fibrin content of an organ was calculated by the formula [151, F = 1/Q(T -CM), where F is the amount of fibrin in mg/organ, Q is the factor conversion of IZ5I radioactivity to mg of fibrin, consisting of the mean relative specific radioactivity of the plasma fibrinogen in control rats, T is the total lZ51 radioactivity/organ and CM is the mean tissue radioactivity in control rats.
Measurements of the renal blood flow and the aortic blood flow
Anaesthesia was induced with a-chloralose and a free airway established by tracheostomy. Plastic catheters were inserted (i) into the right external jugular vein (PP25) for infusions (ii) into the right carotid artery down to the left ventricle of the heart (PPlO) for injection of microspheres, and (iii) into the left femoral artery (PP25) for constant withdrawal of a reference sample. The body temperature was maintained at 38 f l 0 C by an infrared heat-lamp placed above the animal. The renal blood flow and aortic blood flow were measured by the radioactive microsphere method. 3M-Microspheres labelled with 85Sr and lrlCe (specific radioactivity 10 mCi/g, diameter 15 pm, content 5 mg; 0.05 mCi/ml) in 10% (w/v) dextran were used. A 0.05 ml portion of the microsphere suspension (about lo5 spheres) was diluted to 0.20 ml with saline in a plastic syringe and the radioactivity was measured by an external gamma counter device (Canberra). The syringe was shaken for 2 min on a Vibromix and injection was done manually over a period of 15 s via the carotid catheter into the left ventricle of the heart.
Blood was aspirated via the plastic catheter in the left femoral artery (the reference sample) at a constant rate of 0.28 ml/min about 10 s before, during and about 60 s after the injection. The remaining radioactivity in the injection syringe was measured and the injected radioactivity calculated (50-75%).
The microspheres were injected immediately before (85Sr) and after ("lCe) the thrombin infusion and the rats were killed by opening the heart. The left ventricle was inspected to ensure that the tip of the catheter was in the correct position 1-2 mm below the aortic valves. The heart, both lungs and one kidney were dissected free from connective tissue and cleaned with filter paper. The radioactivity of the blood and organ samples was measured in a well-type gammacounter (LKB 1280, Ultrogamma). For conversion of injected into organ radioactivity, standard samples were measured with both gammacounter devices.
Renal blood flow was calculated as 2 x counts in one kidney x 0.28 ml (min-') counts in reference organ and aortic blood flow as (counts injected -counts of heart) x 0.28 ml (min-') counts in reference sample
Plasma renin activity (PRA)
Apart from a decapitated control group, all animals were anaesthetized by an intraperitoneal injection of a-chloralose and were tracheostomized. A catheter was inserted into the right external jugular vein for infusions. Blood was taken from the abdominal aorta and centrifuged at 4OC. A 1 ml portion of plasma was instantly frozen at -2OOC.
PRA assay was done as described by Fyhrquist et al. 116, 171. The pH of the sample was adjusted to 6.0 by a single addition of hydrochloric acid. Hydroxyquinoline was used as an inhibitor of proteolytic enzymes. The incubation time was 1 h at 37OC. With this procedure the recovery of iodinated angiotensin I (ANG I) exceeds 90%. In our laboratory the precision of the method (coefficient of variation for intraassay samples) is 8%.
Statistical methods of rats was tested by Student's t-test.
The significance of differences between groups
Results
Quantification ofjibrin in the kidneys
Influence of saralasin (Table 1 ). The rats were divided into four groups. One of those groups received an infusion of saline for 30 min and then thrombin for 60 min. Another group received saralasin instead of saline. The two remaining groups served as controls and received saline or saralasin instead of thrombin. AU groups received tranexamic acid before the thrombin infusion.
Rats given saralasin + tranexamic acid + thrombin had significantly less fibrin in the kidney and a slightly but insignificantly higher value in the lung. The two groups showed equally decreased concentrations of fibrinogen in plasma.
Influence of angiotensin ZZ ( Table 2 ). The procedure in this experiment was the same as for saralasin above except that saralasin was replaced by ANG 11.
Administration of ANG I1 increased the amount of fibrin in the kidney, but not in the lung. The plasma fibrinogen concentration was equally decreased in both groups.
Znfluence of chronic saline loading (Table 3 ). The following groups were studied: (i) tap-waterdrinking rats, (ii) chronic saline-loaded rats infused with thrombin, (iii) tap-water-drinking rats and (iv) chronic saline-loaded rats infused with saline. All rats received an injection of tranexamic acid. The saline-loaded rats infused with thrombin + tranexamic acid showed a significantly lower amount of fibrin in the kidney than the tap-waterdrinking rats. In the lung no difference was found. The plasma concentrations of fibrinogen in the tap-water-drinking and saline-loaded rats were equally decreased.
Renal bloodflow and aortic bloodflow
Effects of saralasin and angiotensin II ( Table   4 ). The groups were divided into four groups. One received saline before and during the thrombin infusion, another received saralasin, and a third ANG I1 instead of saline. A control group received only saline. All rats received injections of tranexamic acid. Renal and aortic blood flows were measured before and after the thrombin infusion.
Infusion of saline + tranexamic acid + thrombin reduced the renal and aortic blood flows significantly. Saralasin did not prevent the thrombin-induced reductions in the renal and aortic blood flows. Infusion of ANG I1 had already suppressed these blood flows before the thrombin infusion and very low values were noted afterwards. Eflect of chronic saline loading (Table 5) . The groups were similar to those shown in Table 3 .
Chronic saline-loading did not influence the renal and aortic blood flows compared with the tapwater-drinking rats before the thrombin infusion.
After the infusion of thrombin + tranexamic acid the renal blood flow was higher in the salineloaded rats and the aortic blood flow was unchanged compared with the pre-infusion values. + saline (7) TABLE 5. Renal and aortic bloodflows, and decrease in these (A), before and after irlfusion of tranexamic acid (AMCA) i thrombin: effect of chronic saline loading Results are means f sD. Significance of differences between values before and after infusion of thrombin in the same experimental group (P). Significance of differences between values of tap water + AMCA + thrombin and saline loaded + AMCA + thrombin: *P < 0.05. N.S., Not significant. Numbers of rats are shown in parentheses.
Renal blood flow (ml min-I 100 g-l body wt.)
Aortic blood flow (ml min-l LOO 8-l body wt.) Plasma renin activity (Table 6 ) The rats were divided into five groups. One group of rats was killed by decapitation. In another group blood was collected 15 rnin after the injection of tranexamic acid. A third group received 1.2 ml of saline for 60 rnin before sampling. The two remaining groups received thrombin, one for 30 min and another for 60 min.
Before
The PRA of decapitated rats was significantly lower than in all other groups. Neither infusion of saline for 60 rnin nor infusion of thrombin for 30 min changed the PRA. After 60 rnin of thrombin the PRA was significantly lower than among rats given only tranexamic acid. PRA of all animals anaesthetized with achloralose was elevated to over 3 pmol of ANG I h-' ml-' compared with about 1 pmol of ANG I h-' ml-' in the decapitated control rats. This increase is much smaller than in one of our previous studies where about 30 pmol of ANG I h-' ml-' was noted after ether anaesthesia [91. We found no increase in PRA after thrombin infusion as might have been expected because of the impaired renal perfusion. On the contrary, after 60 rnin of thrombin infusion PRA fell to about 5096 of the value before infusion. The explanation is unknown. During the early phase of glycerol-induced aortic blood flow in rats a similar reduction in the PRA was observed by Matthews et al. 1191 , who suggested that this fall was due to an osmotic diuresis.
Discussion
The fall in renal blood flow after thrombin infusion could be explained by mechanical obstruction of the glomerular capillaries by fibrin impeding renal perfusion. However, the fact that saralasin had no effect on the depression of renal blood flow after thrombin, but markedly reduced the fibrin in the kidneys, makes vasoconstriction more probable. Ridegran et al. [20] showed that the increased renal vascular resistance after infusion of thrombin can be prevented by bradykinin. The mediators of such postulated vasoconstriction are not known. ANG I1 is unlikely to be responsible because saralasin failed to prevent the decrease in the renal blood flow and the PRA was not raised during the thrombin infusion in our experiments. The effect of chronic saline loading on the renal blood flow after thrombin could of course be explained by suppression of the renin-angiotensin system, but could also be due to increase in plasma volume as shown by the unchanged aortic blood flow during the thrombin infusion. The sympathetic nervous system could mediate the thrombininduced vasoconstriction in the kidneys, since the jl-adrenoceptor antagonist propranolol prevents suppression of glomerular filtration rate after thrombin infusion [211. It is also possible that substances released from platelets or other blood cells during the coagulation process contribute to the vasoconstriction.
The method for measurement of fibrin content in organs has been found reliable for quantitative studies [ 151. The reduced plasma fibrinogen and the increase in fibrin degradation products in the organs only give minor changes in the radioactivity compared with that of the massive fibrin deposits. Both saralasin and chronic saline loading resulted in reduced fibrin deposition in the kidneys and ANG I1 infusion had the opposite effect. None of these procedures apparently influenced total degree of intravascular coagulation as judged by the consumption of plasma fibrinogen. To our knowledge, the effect of ANG I1 antagonists on the fibrinolysis has not been investigated in the rat. ANG I1 could have enhanced the fibrinolysis as reported by Cho & Choy [22] , but in that study a larger dose of ANG I1 was used and our rats were pretreated with tranexamic acid to prevent fibrinolysis. Increased fibrinolysis due to ANG I1 would have reduced the fibrin content of the kidneys, in contrast to our findings. The degree of fibrin deposition in the kidneys during thrombin infusion therefore appears to be determined directly by ANG 11.
As saralasin reduced the amount of fibrin but had no effect on the fall in renal blood flow after thrombin infusion, the mechanism regulating fibrin deposition appears to be independent of that which reduced the renal blood flow. It is conceivable that ANG I1 influences the deposition of fibrin by separate effects on the glomerular filtration rate. There is evidence that ANG I1 regulates the relative resistance of the afferent and efferent arterioles [23 I and may also have effects on the glomerular capillaries with reduction of the glomerular ultrafiltration coefficient [ 241.
